Takeda Pharmaceutical (TAK) P/E Ratio
P/E Ratio as of Jun 13, 2025: 67.74
Average65.80
Median66.67
Minimum62.39
Maximum68.58
67.74
Past Month+6.64 (10.87%)
The P/E ratio for Takeda Pharmaceutical (TAK) is 67.74 as of Jun 13, 2025. This represents a increase of 80.88% compared to its 12-month average P/E ratio of 37.45. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Takeda Pharmaceutical P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Takeda Pharmaceutical’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Takeda Pharmaceutical to industry peers.
Takeda Pharmaceutical P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Takeda Pharmaceutical’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Takeda Pharmaceutical to industry peers.
Takeda Pharmaceutical (TAK) P/E Ratio Insights
See Takeda Pharmaceutical’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Takeda Pharmaceutical (TAK)
Order type
Buy in
Order amount
Est. shares
0 shares
Takeda Pharmaceutical (TAK) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $15.08 | 67.20 |
| May 1, 2025 | $15.03 | 34.76 |
| Apr 1, 2025 | $14.90 | 34.46 |
| Mar 3, 2025 | $14.84 | 34.32 |
| Feb 3, 2025 | $13.25 | 30.64 |
| Jan 2, 2025 | $13.25 | 21.69 |
Takeda Pharmaceutical (TAK) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 67.74 | +212.60% |
| 2024 | 21.67 | -31.75% |
| 2023 | 31.75 | +9.14% |
| 2022 | 29.09 | +175.47% |
| 2021 | 10.56 | -68.32% |
| 2020 | 33.33 | — |
FAQs About Takeda Pharmaceutical (TAK) P/E ratio
The latest P/E ratio of Takeda Pharmaceutical (TAK) is 67.74, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Takeda Pharmaceutical’s last 12-month average P/E ratio is 37.45, compared to its current P/E ratio of 67.74. This reflects a increase of 80.88%.
Takeda Pharmaceutical’s current P/E ratio of 67.74 is higher than its last 12-month average P/E of 37.45. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Takeda Pharmaceutical’s average P/E ratio over the last 3 years is 31.58. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Takeda Pharmaceutical’s average P/E ratio over the last 5 years is 32.11. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.